Eton Pharmaceuticals share price logo

Eton Pharmaceuticals

NASDAQ: ETON

Small Cap

$59.78

-2.89

(-4.61%)

as on

Eton Pharmaceuticals Stock Performance

as on August 29, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $58.36
    $62.12
    downward going graph

    2.38%

    Downside

    3.91%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $14.27
    $66.37
    downward going graph

    76.13%

    Downside

    11.02%

    Upside

    downward going graph

Eton Pharmaceuticals share price movements today

Previous Close
$62.67
Open
$62.00
Volume
655.4K
Market Cap
$1.8B
Day's Low - High
$58.36 - $62.12
52 Week Low - High
$14.27 - $66.37

Eton Pharmaceuticals Historical Returns

1 Month Return
+ 34.31 %
3 Month Return
+ 96.7 %
1 Year Return
+ 262.67 %
3 Year Return
+ 1230.57 %
5 Year Return
+ 1136.09 %

Eton Pharmaceuticals Stock Fundamentals & Key Indicators

Check Eton Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

1.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.13%

PE Ratio (TTM)

160.56

Industry PE ratio

1.6784

PEG Ratio

0

EBITDA

25.2M

Revenue (TTM)

105.6M

Profit Margin

12.02%

Return On Equity TTM

35.97%

Eton Pharmaceuticals Stock Valuation

Track how Eton Pharmaceuticals P/E has moved over time to understand its valuation trends.

Eton Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-133.63x)

December 31, 2023

Industry (1.68x)

August 28, 2026

Today (160.56x)

August 28, 2026

Highest (109.17x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 160.56x

Eton Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eton Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Eton Pharmaceuticals image
Eton Pharmaceuticals
BUY$1.8B1136.09%160.5612.02%NA
United Therapeutics image
United Therapeutics
BUY$22.6B150.1%16.5886.14%NA
Viatris image
Viatris
HOLD$19.2B17.54%-46.4434.83%2.87%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
BUY$44.4BNA20.7614.55%121.78%
Zoetis image
Zoetis
BUY$31.9B-63.19%12.4770.87%2.76%
See all

Stock Returns calculator for Eton Pharmaceuticals Stock including INR - Dollar returns

The Eton Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Eton Pharmaceuticals investment value today

Current value as on today

₹3,74,957

Returns

₹2,74,957

(+274.96%)

Returns from Eton Pharmaceuticals Stock

₹2,45,949 (+245.95%)

Dollar Impact

₹29,008 (+29.01%)

Analyst Recommendation on Eton Pharmaceuticals Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Eton Pharmaceuticals. Average target price of $71

Eton Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Eton Pharmaceuticals.

What analysts predicted

15.8%UPSIDE

Target Price

$71

Current Price

$59.78

Analyzed by

4 Analysts

Target

$71.00

Eton Pharmaceuticals target price $71, a slight upside of 15.8% compared to current price of $59.78. According to 4 analysts rating.

Indian Investors' Interest in Eton Pharmaceuticals Stock

Investment in Eton Pharmaceuticals Shares on INDmoney has grown by 161.90% in the last 30 days, indicating increased investment activity.

Time period: to

Change:161.90% versus previous 30 day period

Search interest for Eton Pharmaceuticals Stock has increased by 262% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:262% versus previous 30 day period

Eton Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
7
9
10
11
17
18
22
21
24
37
Gross Profit
5
5
6
6
9
11
7
13
14
25
Operating Income
0
-2
0
0
0
-1
-1
2
2
12
EBITDA
0
-2
0
0
0
0
0
3
1
12
Interest Expense
0
0
0
1
1
1
1
1
0
1
Depreciation
0
0
0
0
1
1
1
1
1
-
Income Before Tax
0
-2
0
0
-1
-2
-1
1
1
11
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
0
-3
0
0
-1
-2
-1
1
1
11
Net Profit Margin
-10.18%
-33.51%
6.07%
-5.13%
-9.10%
-13.66%
-8.58%
6.97%
6.40%
30.80%

Eton Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
0
21
21
31
39
79
Gross Profit
0
0
0
0
19
14
21
23
42
Operating Income
-7
-10
-18
-27
-1
-8
-1
-2
0
EBITDA
-7
-10
-18
-26
-1
-7
0
0
4
Interest Expense
-
0
0
0
1
0
1
2
4
Depreciation
-
0
0
0
0
1
0
1
4
Income Before Tax
-7
-12
-18
-27
-1
-9
0
-3
-4
Income Tax Expense
-
-2
0
0
1
0
0
0
0
Net Income
-7
-12
-18
-27
-1
-9
0
-3
-4
Net Profit Margin
0.00%
0.00%
-1910.32%
-71717.95%
-8.95%
-42.45%
-2.96%
-9.80%
-5.75%

Eton Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
0
0
-1
-2
-1
1
1
11
Operating Cash Flow
1
2
0
2
7
12
-11
7
7
Investing Cash Flow
-
1
-38
-
-
0
0
-15
0
Financing Cash Flow
0
0
33
0
-
-
0
1
0
Change in Cash
1
2
-5
2
7
11
-11
-6
7

Eton Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-18
-27
-1
-9
0
-3
-4
Operating Cash Flow
-8
-18
-22
-4
4
6
0
10
Investing Cash Flow
0
-1
0
-2
-2
0
-40
0
Financing Cash Flow
21
5
31
0
0
0
32
0
Change in Cash
13
-14
9
-6
1
5
-6
11

Mutual Funds that own Eton Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Eton Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.404759%
973187
Fidelity Salem Street Trust
0.966709%
276316
Fidelity Concord Street Trust
0.834901%
238641
VANGUARD SCOTTSDALE FUNDS
0.53435%
152734
SCHWAB CAPITAL TRUST
0.240571%
68763
See all

Global Institutional Holdings in Eton Pharmaceuticals

Funds
Holdings
Vanguard
4.24%
iShares
3.88%
Michael Rockefeller
1.09%
SPDR
1.05%
Principal
0.19%
See all

Eton Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 27 August

    Thu, 04:20 PM

    -

    Eton Pharmaceuticals to host 1x1 meetings on September 9, 2026, at the Wells Fargo Healthcare Conference in Boston.

Insights on Eton Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ETON stock has moved up by 96.3%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 21.28M → 37.58M (in $), with an average increase of 23.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, -2.58M → 11.57M (in $), with an average increase of 88.8% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ETON has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ETON has outperformed top 5 stocks with highest market-cap in its industry

About Eton Pharmaceuticals

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
OrganisationEton Pharmaceuticals
Headquarters21925 W. Field Parkway, Deer Park, IL, United States, 60010-7278
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Sean E. Brynjelsen
E-voting on sharesClick here to vote

Key Management of Eton Pharmaceuticals

Name

Title

Mr. Sean E. Brynjelsen

President, CEO & Director

Mr. David C. Krempa

Chief Business Officer

Mr. James R. Gruber CPA

Consultant

Ms. Ipek Erdogan-Trinkaus

Chief Commercial Officer

Ms. Judith M. Matthews

Chief Financial Officer & Secretary

Ms. Danka Radosavljevic

Chief Operating Officer

Mr. Scott Grossenbach

Senior Vice President of Sales Operations

FAQs

What is Eton Pharmaceuticals share price today?

Eton Pharmaceuticals share price today is $59.78 as on at the close of the market. Eton Pharmaceuticals share today touched a day high of $62.12 and a low of $58.36.

What is the 52 week high and 52 week low for Eton Pharmaceuticals share?

Eton Pharmaceuticals share touched a 52 week high of $66.37 on and a 52 week low of $14.27 on . Eton Pharmaceuticals stock price today i.e. is closed at $59.78,which is 9.93% down from its 52 week high and 318.92% up from its 52 week low.

What is Eton Pharmaceuticals's market capitalisation today?

Eton Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Eton Pharmaceuticals Stock (ETON) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Eton Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eton Pharmaceuticals Shares that will get you 0.0251 shares as per Eton Pharmaceuticals share price of $59.78 per share as on August 29, 2026 at 8:45 am IST.

What is the minimum amount required to buy Eton Pharmaceuticals Stock (ETON) from India?

Indian investors can start investing in Eton Pharmaceuticals (ETON) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Eton Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Eton Pharmaceuticals share’s latest price of $59.78 as on August 29, 2026 at 8:45 am IST, you will get 0.1673 shares of Eton Pharmaceuticals. Learn more about fractional shares .

What are the returns that Eton Pharmaceuticals has given to Indian investors in the last 5 years?

Eton Pharmaceuticals stock has given 1136.09% share price returns and 30.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?